Cellromax Science Co., Ltd. Logo

Cellromax Science Co., Ltd.

Develops health foods, derma-cosmetics, and OTC drugs for pharmacies and online channels.

471820 | KO

Overview

Corporate Details

ISIN(s):
KR7471820001
LEI:
Country:
South Korea
Address:
경기도 용인시 기흥구 구성로 357 D동 710호 (청덕동, 용인테크노밸리), 용인시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cellromax Science Co., Ltd. is a KOSDAQ-listed company specializing in the development, manufacturing, and distribution of health-oriented products. Its primary business divisions include health functional foods, derma-cosmetics, and over-the-counter (OTC) pharmaceuticals. The company focuses on creating differentiated products through dedicated research, using carefully selected natural-origin raw materials and optimal formulation science. Key product features include specialized prescriptions and user-friendly formulation technology. Cellromax Science distributes its products through pharmacies and direct-to-consumer online channels. The company was formerly known as Pharmacist & Health Co., Ltd. and rebranded in 2021.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-12 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정 (분기배당)
Korean 8.1 KB
2025-09-12 00:00
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean 5.5 KB
2025-09-01 00:00
Share Issue/Capital Change
감자완료
Korean 8.9 KB
2025-08-27 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-08-13 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(감자결정)
Korean 22.5 KB
2025-08-12 00:00
Share Issue/Capital Change
[기재정정]전환청구권행사 (제1회차)
Korean 11.8 KB
2025-07-23 00:00
Post-Annual General Meeting Information
임시주주총회결과
Korean 5.6 KB
2025-07-22 00:00
Share Issue/Capital Change
전환청구권행사 (제1회차)
Korean 8.7 KB
2025-07-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-07-10 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-07-09 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정 (분기배당)
Korean 8.8 KB
2025-07-09 00:00
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약체결결정)
Korean 35.5 KB
2025-07-08 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 58.7 KB
2025-07-07 00:00
Regulatory News Service
신탁계약해지결과보고서
Korean 35.1 KB
2025-06-13 00:00
Notice of Dividend Amount
수시공시의무관련사항(공정공시) (주주가치 제고를 위한 주주환원계획 수립)
Korean 8.8 KB

Automate Your Workflow. Get a real-time feed of all Cellromax Science Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cellromax Science Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cellromax Science Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

IGC Pharma, Inc. Logo
Clinical-stage pharma creating Alzheimer's therapies & AI-powered diagnostics.
United States of America
IGC
IL DONG PHARMACEUTICAL CO., LTD. Logo
Develops & manufactures pharmaceuticals, APIs, and offers CMO services for various diseases.
South Korea
249420
ILSUNG IS CO., LTD. Logo
Develops pharmaceuticals like antibiotics and anesthetics, expanding into CNS and GI therapies.
South Korea
003120
ILYANG PHARMACEUTICAL CO.,LTD Logo
Develops & manufactures drugs, vaccines & supplements for oncology & gastroenterology needs.
South Korea
007570
I-Mab Logo
A clinical-stage biopharma developing immuno-oncology agents and bispecific antibodies for cancer.
United States of America
IMAB
ImageneBio, Inc. Logo
A clinical-stage biopharma pioneering therapies for immune & inflammatory diseases.
United States of America
IMA
IM Cannabis Corp. Logo
International producer of medical-grade cannabis for patients and providers in Israel and Germany.
United States of America
IMCC
Immatics N.V. Logo
Develops T-cell redirecting immunotherapies (ACT & TCR Bispecifics) for solid tumor cancers.
United States of America
IMTX
Immix Biopharma, Inc. Logo
Developing safer cell therapies for AL Amyloidosis and hematologic malignancies.
United States of America
IMMX
IMMUCELL CORP /DE/ Logo
Develops biotech health products for disease prevention in dairy and beef cattle.
United States of America
ICCC

Talk to a Data Expert

Have a question? We'll get back to you promptly.